Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference23 articles.
1. Clark LT, Watkins L, Piña IL, Elmer M, Akinboboye O, Gorham M, Jamerson B, McCullough C, Pierre C, Polis AB, Puckrein G, Regnante JM. Increasing diversity in clinical trials: overcoming critical barriers. Curr Probl Cardiol. 2019;44(5):148–72. https://doi.org/10.1016/j.cpcardiol.2018.11.002.
2. Lewis MJ, Jawad AS. The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. Rheumatology (Oxford). 2017;56(suppl_1):i67–77. https://doi.org/10.1093/rheumatology/kew399.
3. Hung RKY, Binns-Roemer E, Booth JW, Hilton R, Fox J, Burns F, Harber M, Ustianowski A, Hamzah L, Burns JE, Clarke A, Price DA, Kegg S, Onyango D, Santana-Suarez B, Campbell L, Bramham K, Sharpe CC, Sabin CA, Winkler CA, et al. Sickle cell trait and kidney disease in people of African ancestry with HIV. Kidney Int Rep. 2021;7(3):465–73. https://doi.org/10.1016/j.ekir.2021.12.007.
4. National Academies of Sciences, Engineering, and Medicine. 2022. Improving representation in clinical trials and research: building research equity for women and underrepresented groups. Washington, DC: The National Academies Press. https://doi.org/10.17226/26479.
5. Government Accountability Office. 2022. Cancer clinical trials: federal actions and selected non-federal practices to facilitate diversity of patients. (GAO-23-105245). Washington, D.C.: U.S. Government Printing Office. Retrieved from https://www.gao.gov/products/gao-23-105245